Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features, treatment options and outcomes in primary cutaneous B-cell lymphomas: a real-world, multicenter, retrospective study.
Nikolaou V, Koumprentziotis IA, Papadavid E, Patsatsi A, Diavati S, Tsimpidakis A, Kruger-Krasagakis S, Doxastaki A, Marinos L, Kaliampou S, Gerochristou M, Koumourtzis M, Pappa V, Kypraiou E, Kouloulias V, Angelopoulos K, Machairas A, Vassilakopoulos T, Papadopoulou V, Tsamaldoupis A, Georgiou E, Koletsa T, Stratigos A, Siakantaris M, Angelopoulou M. Nikolaou V, et al. Among authors: koumprentziotis ia. Int J Dermatol. 2024 Nov 11. doi: 10.1111/ijd.17564. Online ahead of print. Int J Dermatol. 2024. PMID: 39526550
Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective study.
Rompoti N, Koumprentziotis IA, Stefanaki I, Vavouli C, Papoutsaki M, Politou M, Panagakis P, Befon A, Kousta F, Lazou E, Chasapi V, Stratigos A, Nicolaidou E. Rompoti N, et al. Among authors: koumprentziotis ia. Arch Dermatol Res. 2024 Oct 9;316(9):667. doi: 10.1007/s00403-024-03419-w. Arch Dermatol Res. 2024. PMID: 39382588 No abstract available.
Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study.
Nikolaou V, Panou E, Tsimpidakis A, Koumprentziotis IA, Patsatsi A, Siakantaris M, Kruger-Krasagakis SE, Marinos L, Georgiou E, Lampadaki K, Velissari A, Daponte AI, Doxastaki A, Kaliampou S, Vaiopoulos A, Konstandinou I, Koumourtzis M, Lakiotaki E, Pappa V, Tsamaldoupis A, Stratigos A, Papadavid E. Nikolaou V, et al. Among authors: koumprentziotis ia. J Eur Acad Dermatol Venereol. 2024 Sep 19. doi: 10.1111/jdv.20350. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39297278
Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas.
Rompoti N, Vergou T, Stefanaki I, Vavouli C, Koumprentziotis IA, Panagakis P, Papoutsaki M, Politou M, Befon A, Kousta F, Lazou E, Zaimi M, Chasapi V, Stratigos A, Nicolaidou E. Rompoti N, et al. Among authors: koumprentziotis ia. Int J Dermatol. 2024 Oct;63(10):e255-e258. doi: 10.1111/ijd.17400. Epub 2024 Jul 25. Int J Dermatol. 2024. PMID: 39051109 No abstract available.
Total IgE Trends in Children with Allergic Diseases.
Katsanakis N, Xepapadaki P, Koumprentziotis IA, Vidalis P, Lakoumentas J, Kritikou M, Papadopoulos NG. Katsanakis N, et al. Among authors: koumprentziotis ia. J Clin Med. 2024 Jul 8;13(13):3990. doi: 10.3390/jcm13133990. J Clin Med. 2024. PMID: 38999554 Free PMC article.
Bimekizumab in psoriasis: a monocentric study evaluating short- and mid-term effectiveness and safety profile in a real-world setting.
Rompoti N, Stefanaki I, Panagakis P, Vavouli C, Politou M, Papoutsaki M, Befon A, Koutsa F, Lazou E, Koumprentziotis IA, Chasapi V, Stratigos A, Nicolaidou E. Rompoti N, et al. Among authors: koumprentziotis ia. Arch Dermatol Res. 2024 Apr 25;316(5):133. doi: 10.1007/s00403-024-02868-7. Arch Dermatol Res. 2024. PMID: 38662223
20 results